Breaking News Instant updates and real-time market news.

URGN

UroGen Pharma

$59.56

-3.67 (-5.80%)

07:06
04/06/18
04/06
07:06
04/06/18
07:06

UroGen Pharma price target raised to $75 from $62 at Oppenheimer

Oppenheimer analyst Derek Archila raised his price target on UroGen Pharma to $75 from $62. Archila told investors in a research note that he is increasing his probability of success for MitoGel in upper tract urothelial carcinoma, or UTUC, based on "impressive" interim results from its OLYMPUS Phase 3 study, in which the complete response rate was better than seen in the compassionate use study. Archila reiterated an Outperform rating on UroGen shares.

URGN UroGen Pharma
$59.56

-3.67 (-5.80%)

11/15/17
OPCO
11/15/17
NO CHANGE
Target $51
OPCO
Outperform
UroGen Pharma price target raised to $51 from $32 at Oppenheimer
Oppenheimer analyst Derek Archila raised his price target for UroGen Pharma to $51 from $32 after the company reported a Q3 financial and business update. The analyst remains positive on the shares ahead of UroGen's top line data from its OLYMPUS study evaluating MitoGel in patients with low grade upper tract urothelial carcinoma and views MitoGel as a potential game-changer in the way this indication is treated. Archila reiterates an Outperform rating on the shares.
11/15/17
RAJA
11/15/17
DOWNGRADE
RAJA
Market Perform
UroGen Pharma downgraded to Market Perform from Outperform at Raymond James
As previously reported, Raymond James downgraded UroGen Pharma to Market Perform from Outperform. Analyst Reni Benjamin said shares have surpassed his bull case target of $33 and valuation reflects the commercial prospects and risks of the pipeline products including MitoGel and VesiGel.
03/16/18
LTCO
03/16/18
NO CHANGE
Target $65
LTCO
Buy
UroGen Pharma price target raised to $65 from $50 at Ladenburg
Ladenburg Thalmann analyst Matthew Kaplan raised his price target for UroGen Pharma to $65 and reiterates a Buy rating on the shares following the company's Q4 results. Interim Phase 3 MitoGel data for the treatment of low-grade upper tract urothelial carcinoma are expected in Q2. Kaplan tells investors in a research note. The analyst is encouraged by the Phase 2 results and believe there is strong likelihood for a positive readout for the study.
04/04/18
RAJA
04/04/18
UPGRADE
RAJA
Outperform
UroGen Pharma upgraded to Outperform from Market Perform at Raymond James

TODAY'S FREE FLY STORIES

01:45
08/14/18
08/14
01:45
08/14/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap:…

BCE

BCE

$40.57

0.045 (0.11%)

21:57
08/13/18
08/13
21:57
08/13/18
21:57
Upgrade
BCE rating change at Edward Jones »

BCE upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$13.96

-0.11 (-0.78%)

21:55
08/13/18
08/13
21:55
08/13/18
21:55
Downgrade
Switch rating change at Raymond James »

Switch downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

FDC

First Data

$23.90

-0.78 (-3.16%)

21:55
08/13/18
08/13
21:55
08/13/18
21:55
Syndicate
First Data 64M share Secondary priced at $23.75 »

Citi acted as lead book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 14

    Aug

ARDS

Aridis Pharmaceuticals

$0.00

(0.00%)

21:54
08/13/18
08/13
21:54
08/13/18
21:54
Syndicate
Aridis Pharmaceuticals 2M share IPO priced at $13.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

JPM

JPMorgan

$113.88

-1.8 (-1.56%)

20:52
08/13/18
08/13
20:52
08/13/18
20:52
Periodicals
JPMorgan to stop offering investment accounts to foreign clients, Bloomberg says »

JPMorgan will discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

BIIB

Biogen

$340.67

-2.54 (-0.74%)

20:47
08/13/18
08/13
20:47
08/13/18
20:47
Periodicals
UK's NICE: Biogen's Spinraza too expensive for health service, Reuters reports »

U.K.'s National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

HD

Home Depot

$194.11

-2.19 (-1.12%)

, TPR

Tapestry

$47.42

-0.52 (-1.08%)

20:25
08/13/18
08/13
20:25
08/13/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

HD

Home Depot

$194.11

-2.19 (-1.12%)

TPR

Tapestry

$47.42

-0.52 (-1.08%)

AAP

Advance Auto Parts

$144.79

-1.52 (-1.04%)

EAT

Brinker

$43.81

-0.37 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 12

    Sep

HIL

Hill International

$5.65

(0.00%)

19:45
08/13/18
08/13
19:45
08/13/18
19:45
Hot Stocks
Hill International provides update on NYSE notice of delisting »

Hill Internationa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NVDA

Nvidia

$256.08

1.38 (0.54%)

19:36
08/13/18
08/13
19:36
08/13/18
19:36
Hot Stocks
Nvidia launches Turing GPU architecture in computer graphics »

NVIDIA today reinvented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

ESRX

Express Scripts

$84.04

0.39 (0.47%)

, CI

Cigna

$181.78

-1.59 (-0.87%)

19:33
08/13/18
08/13
19:33
08/13/18
19:33
Hot Stocks
Carl Icahn says will no longer vote against Cigna/Express Scripts deal »

Today Carl Icahn released…

ESRX

Express Scripts

$84.04

0.39 (0.47%)

CI

Cigna

$181.78

-1.59 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 24

    Aug

  • 24

    Aug

MEOH

Methanex

$71.55

-0.45 (-0.63%)

19:17
08/13/18
08/13
19:17
08/13/18
19:17
Hot Stocks
Methanex signs natural gas supply agreement for Chile operations »

Methanex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PERY

Perry Ellis

$29.10

-0.03 (-0.10%)

19:16
08/13/18
08/13
19:16
08/13/18
19:16
Periodicals
Randa nearing decision on competing Perry Ellis bid, WWD reports »

Randa is in talks with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCBK

TriCo Bancshares

$39.20

-0.14 (-0.36%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Hot Stocks
TriCo Bancshares names Peter Wiese as CFO, effective August 14 »

TriCo Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 07

    Nov

ARQL

ArQule

$5.67

0.21 (3.85%)

, YEXT

Yext

$22.57

-0.18 (-0.79%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: ArQule (ARQL) up…

ARQL

ArQule

$5.67

0.21 (3.85%)

YEXT

Yext

$22.57

-0.18 (-0.79%)

CWT

California Water Service

$40.05

-0.4 (-0.99%)

SJW

SJW Corp.

$62.49

0.74 (1.20%)

VERI

Veritone

$15.81

1.05 (7.11%)

SWCH

Switch

$13.96

-0.11 (-0.78%)

VIPS

Vipshop

$8.98

-0.15 (-1.64%)

SAIL

SailPoint

$28.39

-0.43 (-1.49%)

RH

RH

$151.63

7.175 (4.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 13

    Aug

  • 14

    Aug

  • 04

    Sep

  • 04

    Sep

  • 10

    Sep

  • 16

    Aug

ROSE

Rosehill Resources

$8.36

-0.09 (-1.07%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Earnings
Rosehill Resources reports Q2 net income $8.7M vs. loss ($1.4M) last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

CMC

Commercial Metals

$21.80

0.11 (0.51%)

18:49
08/13/18
08/13
18:49
08/13/18
18:49
Upgrade
Commercial Metals rating change at Goldman Sachs »

Commercial Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

KALU

Kaiser Aluminum

$109.76

-1.35 (-1.22%)

18:44
08/13/18
08/13
18:44
08/13/18
18:44
Downgrade
Kaiser Aluminum rating change at Goldman Sachs »

Kaiser Aluminum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTA

Establishment Labs

$27.10

0.66 (2.50%)

18:09
08/13/18
08/13
18:09
08/13/18
18:09
Initiation
Establishment Labs initiated at BTIG »

Establishment Labs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

BRK.A

Berkshire Hathaway

$310,200.00

-1950 (-0.62%)

, BRK.B

Berkshire Hathaway

$205.17

-1.365 (-0.66%)

18:08
08/13/18
08/13
18:08
08/13/18
18:08
Hot Stocks
Berkshire Hathaway comments on quarterly reporting on Form 13F »

"Tomorrow afternoon,…

BRK.A

Berkshire Hathaway

$310,200.00

-1950 (-0.62%)

BRK.B

Berkshire Hathaway

$205.17

-1.365 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRO

Pros Holdings

$39.80

-0.2 (-0.50%)

18:06
08/13/18
08/13
18:06
08/13/18
18:06
Syndicate
PROS Holdings 450K share Block Trade; price range $7.60-$7.80 »

Barclays is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 14

    Aug

  • 20

    Aug

  • 21

    Aug

  • 16

    Aug

YY

YY

$87.72

-1.09 (-1.23%)

18:06
08/13/18
08/13
18:06
08/13/18
18:06
Earnings
Breaking Earnings news story on YY »

YY sees Q3 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 10

    Sep

ICUI

ICU Medical

$293.00

0.85 (0.29%)

18:05
08/13/18
08/13
18:05
08/13/18
18:05
Syndicate
ICU Medical 700K share Block Trade; price range $287-$290 »

Barclays is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

YY

YY

$87.72

-1.09 (-1.23%)

18:05
08/13/18
08/13
18:05
08/13/18
18:05
Earnings
YY reports Q2 adjusted EPS $2.03, consensus $1.77 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 10

    Sep

LAC

Lithium Americas

$3.56

-0.17 (-4.56%)

, SQM

SQM

$45.68

-1.16 (-2.48%)

18:03
08/13/18
08/13
18:03
08/13/18
18:03
Hot Stocks
Lithium Americas to partner with Ganfeng Lithium in Cauchari-Olaroz »

Lithium Americas (LAC) is…

LAC

Lithium Americas

$3.56

-0.17 (-4.56%)

SQM

SQM

$45.68

-1.16 (-2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.